Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)

1.2 / 5 stars · 16/66 Roast Me

Q/C Technologies, Inc. Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)

Q/C Technologies, Inc. (QCLS) reported Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) of $5.21 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnSaleOfSecuritiesNet · last filed 2015-11-13

  • Q/C Technologies, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $5.21K, a 485.07% increase year-over-year.
  • Q/C Technologies, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $2.44K, a 2114.55% increase year-over-year.
  • Q/C Technologies, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $448.00, a 1020.00% increase year-over-year.
  • Q/C Technologies, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $110.00.
  • Q/C Technologies, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for fiscal 2014 was $861.00, a 682.73% increase from fiscal 2013.
  • Q/C Technologies, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for fiscal 2013 was $110.00.
Period endGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 3 monthGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 6 monthGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 monthGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 12 month
2015-09-30$5.21K
10-Q · filed 2015-11-13
$7.65K
derived: sum of 2 quarters · filed 2015-11-13
$7.20K
10-Q · filed 2015-11-13
$8.21K
derived: sum of 4 quarters · filed 2015-11-13
2015-06-30$2.44K
10-Q · filed 2015-08-18
$1.99K
10-Q · filed 2015-08-18
$2.99K
derived: sum of 3 quarters · filed 2015-08-18
$3.88K
derived: sum of 4 quarters · filed 2015-11-13
2015-03-31$448.00
10-Q · filed 2015-05-14
$558.00
derived: sum of 2 quarters · filed 2015-05-14
$1.45K
derived: sum of 3 quarters · filed 2015-11-13
$1.56K
derived: sum of 4 quarters · filed 2015-11-13
2014-12-31$110.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$1.00K
derived: sum of 2 quarters · filed 2015-11-13
$1.11K
derived: sum of 3 quarters · filed 2015-11-13
$861.00
10-K · filed 2015-03-23
2014-09-30$891.00
10-Q · filed 2015-11-13
$1.00K
derived: sum of 2 quarters · filed 2015-11-13
$751.00
10-Q · filed 2015-11-13
2014-06-30$110.00
10-Q · filed 2015-08-18
$70.00
10-Q · filed 2015-08-18
2014-03-31$40.00
10-Q · filed 2015-05-14
2013-12-31$110.00
10-K · filed 2015-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92